AGAVE BIOSYSTEMS INC.

Basic Information

401 E STATE ST STE 200
ITHACA, NY, 14850-4400

Company Profile

n/a

Additional Details

Field Value
DUNS: 022552900
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Identification of Patients with Clostridium Difficile Infection, Colonization and/or Reoccurrence

    Amount: $150,000.00

    Clostridium difficile infection (CDI) results in excess of 14,000 deaths and over $1 billion in excess healthcare costs annually. Early and reliable diagnosis is key for both improving treatment outco ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. Intracellular Detection of Small Molecules in Live Cells

    Amount: $711,624.00

    ABSTRACT: Protection of first responders who are exposed to hazards including chemical warfare agents (CWAs) is a very critical need. The need is derived from not only their welfare but their abilit ...

    STTR Phase II 2014 Air ForceDepartment of DefenseDepartment of Defense
  3. High-capacity and Cost-effective Manufacture of Chloroperoxidase

    Amount: $374,999.00

    The chloroperoxidase enzyme from the filamentous fungus Caldariomyces fumago has applications in industrial chemical synthesis and the detection and inactivation of chemical warfare agents. Chloroper ...

    STTR Phase II 2013 Department of DefenseArmyDepartment of Defense
  4. Multiplex Immunoassays in the Development of Vaccines Against Enteric Pathogens

    Amount: $1,149,993.00

    Bacterial enteric pathogens causing travelers"diarrhea (TD) in developing countries include enterotoxigenic E. coli (50%), Camplyobacter jejuni, Shigella sonnei and Shigella flexneri, while Norov ...

    SBIR Phase II 2013 Department of DefenseArmyDepartment of Defense
  5. Probiotics for Maintaining Dolphin (Tursiops truncatus) Health and the Readiness of the U.S. Navy"s Marine Mammal Systems

    Amount: $79,999.00

    Agave BioSystems, with their academic partners at the Mote Marine Laboratory, proposes to develop probiotic pharmaceuticals from indigenous commensal microbes to enhance gastrointestinal health in the ...

    STTR Phase I 2013 NavyDepartment of DefenseDepartment of Defense
  6. PNA-Based Rapidly Adaptable Anti-Microbial Nanoparticles

    Amount: $1,000,000.00

    Wound management becomes increasingly challenging due to bacterial infections, especially from epidemic drug-resistant strains. To address this problem, Agave BioSystems proposes to develop a RANT (R ...

    SBIR Phase II 2013 Defense Advanced Research Projects AgencyDepartment of DefenseDepartment of Defense
  7. Ionic Liquid-Based Dried Biological Specimen Materials

    Amount: $100,000.00

    Dried blood spots (DBS) analysis has many advantages over standard liquid blood sample testing including: small sample size, ease of blood sampling, room temperature storage, minimal storage size requ ...

    SBIR Phase I 2012 Department of DefenseDefense Advanced Research Projects AgencyDepartment of Defense
  8. Combinatorial PNA-CPP Molecules Targeting Plasmid Transfer and Replication to Control Antibiotic Resistance

    Amount: $99,999.00

    One major cause of the widespread of drug-resistant and virulent bacteria pathogen is the horizontal gene transfer of resistance and virulence genes in the form of plasmids. As proof-of concept for t ...

    SBIR Phase I 2012 Department of DefenseDefense Advanced Research Projects AgencyDepartment of Defense
  9. Antimicrobial Drug Targeted to Essential Bacterial Genes in Wound Infection Pathogens

    Amount: $100,000.00

    Wounds infected with drug-resistant Gram-negative bacteria can increase morbidity, hospital length of stay and cost. Among these Klebsiella pneumoniae and Pseudomonas aeruginosa have become important ...

    SBIR Phase I 2012 Department of DefenseArmyDepartment of Defense
  10. Yeast-Based High-Throughput Screens for Inhibitors of Key Flaviviral Enzymes

    Amount: $100,000.00

    With no clinically approved antiviral therapy available for treatment of flavivirus infections, the development of efficient vaccines and antiviral agents for prevention and treatment of infections is ...

    SBIR Phase I 2012 Department of DefenseArmyDepartment of Defense

Agency Micro-sites

US Flag An Official Website of the United States Government